Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensified Alkylating Agents in HRD+ Breast Cancer
NCT00448266Phase 3Terminated
- Sponsor
- Netherlands Cancer Institute
- Start
- May 2007
- Primary completion
- Feb 2010
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of carboplatin, thiotepa, cyclophosphamide in breast cancer, sponsored by Netherlands Cancer Institute. Started May 2007; status: terminated.
02
Drugs
carboplatinthiotepacyclophosphamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00448266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00448266.